A. Iwata et al., Liposome-mediated gene transfection of endothelial nitric oxide synthase reduces endothelial activation and leukocyte infiltration in transplanted hearts, CIRCULATION, 103(22), 2001, pp. 2753-2759
Citations number
27
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-During cardiac ischemia-reperfusion injury, neutrophilic infiltr
ation of the myocardium is mediated by adhesion molecule expression on acti
vated coronary endothelium. Nitric oxide inhibits neutrophil adhesion to en
dothelium in vitro by blocking the nuclear factor (NF)-kappaB-dependent tra
nscription of adhesion molecules. We investigated whether intraoperative ge
ne delivery of endothelial nitric oxide synthase (eNOS) into donor hearts b
efore transplantation would have a similar effect on an entire organ.
Methods and Results-In an allogeneic rabbit heart transplant model, liposom
es complexed to the gene encoding eNOS were infused into the donor coronary
circulation before transplantation. By 24 hours after transplantation, cal
cium-dependent nitrite production was significantly higher in eNOS-transfec
ted donor hearts than in the 3 control groups: donor hearts transfected wit
h empty plasmids alone, donor hearts treated with diluent only, and untrans
planted native hearts. Intramyocardial neutrophil and T-lymphocyte populati
ons were halved in eNOS-transfected hearts compared with control donor hear
ts (P < 0.05). Moreover, the prevalence of NF-kappaB activation in microvas
cular endothelial cells and surrounding cardiac myocytes as well as endothe
lial vascular cell adhesion molecule-1 and intracellular adhesion molecule-
1 expression were all significantly reduced in eNOS-transfected hearts comp
ared with control donor hearts (P < 0.01). Without immunosuppression, eNOS-
transfected hearts survived longer than controls.
Conclusions-Intraoperative liposome-mediated gene delivery of eNOS to donor
hearts can result in early gene expression sufficient to reduce ischemia-r
eperfusion injury by inhibiting NF-kappaB activation, adhesion molecule exp
ression, and the early infiltration of leukocytes, all of which may improve
graft survival.